548. Baseline characteristics associated with clinical improvement and mortality in hospitalized patients with moderate COVID-19

BACKGROUND: Remdesivir (RDV) has been shown to shorten recovery time and was well tolerated in patients with severe COVID-19. Here we report baseline characteristics associated with clinical improvement at day (d) 14. METHODS: We enrolled hospitalized patients with confirmed SARS-CoV-2 infection, ox...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Castagna, Antonella, Hui, David Shu Cheong, Mullane, Kathleen M, Jain, Mamta, Galli, Massimo, Chang, Shan-Chwen, Hyland, Robert H, SenGupta, Devi, Cao, Huyen, Huang, Hailin, Chokkalingam, Anand, Osinusi, Anu, Brainard, Diana M, Lübbert, Christoph, Lye, David Chien Boon, Aberg, Judith A, Elorza, Enrique Navas, Tashima, Karen T, McPhail, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Poster Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7778131/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.742
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados